What is Clonidine 150 mg used for?

Technical Correction: Standard tablet dosages for Clonidine are typically 100 mcg (0.1 mg), 150 mcg (0.15 mg), or 200 mcg (0.2 mg). A dose of 150 mg would be 1,000 times the standard therapeutic dose and would be considered a lethal overdose. I will proceed with the technical profile for the 150 mcg (0.15 mg) strength, which is a common international standard.

Primary Clinical Uses

  • Hypertension: Used as a second-line treatment for high blood pressure, particularly in cases of “resistant hypertension” where other agents have failed.

  • ADHD (Attention Deficit Hyperactivity Disorder): Used (often as an extended-release formulation) to treat ADHD in children and adults, frequently as an adjunct to stimulants to manage impulsivity and sleep issues.

  • Withdrawal Management: Extensively utilized to manage the physical symptoms of opioid, alcohol, and nicotine withdrawal (such as tachycardia, sweating, and agitation).

  • Pain Management: Used off-label for chronic pain conditions, including neuropathic pain and migraine prophylaxis.

  • Menopausal Symptoms: Occasionally prescribed to reduce the frequency and severity of hot flashes.

Mechanism of Action

Clonidine acts by stimulating $\alpha_2$-adrenoceptors in the brainstem (specifically the vasomotor center of the medulla).

This stimulation results in a reduction of sympathetic outflow from the central nervous system to the heart, kidneys, and peripheral vasculature. The result is a decrease in peripheral resistance, a decrease in heart rate, and a decrease in blood pressure. It essentially “quiets” the body’s adrenaline-driven stress response at the source.

The Manufacturer’s Perspective: Formulation & Export

From a manufacturing and global trade standpoint, Clonidine is a high-precision, low-dose molecule:

  • Micro-Dose Content Uniformity: Since the active ingredient is in micrograms, as a WHO-GMP manufacturer, we utilize validated trituration and geometric dilution processes. This ensures the minute amount of API is perfectly distributed across the excipient matrix to avoid batch failure.

  • Stability & Shelf Life: While the molecule is relatively stable, we prioritize Alu-Alu blister packaging to protect against moisture and light, ensuring a 36-month shelf life for export to Zone IVb regions.

  • B2B & Niche Demand: While not a “mass-market” drug, it is a high-value niche product for psychiatric and hypertension clinics. Our Mumbai-based facility provides the CTD/eCTD Dossiers required for international registration.

  • Safety Warning (Rebound Hypertension): As a pharmacist, you are aware that abrupt cessation can cause a hypertensive crisis. We ensure our professional labeling and Product Information Leaflets (PIL) carry clear warnings regarding gradual tapering.

What is Clonazepam 2mg used for?

In the pharmaceutical industry, Clonazepam 2 mg is a potent, long-acting benzodiazepine of the nitrobenzodiazepine class. As a pharmacist, you recognize this as a high-strength dosage, typically reserved for the management of severe seizure disorders or acute panic states where a sustained therapeutic effect is required.

Primary Clinical Uses

  • Epilepsy and Seizure Disorders: Indicated as standalone or adjunctive therapy for Lennox-Gastaut syndrome (petit mal variant), akinetic, and myoclonic seizures. It is also used for absence seizures that do not respond to succinimides.

  • Panic Disorder: Used to treat panic attacks, with or without agoraphobia, by significantly reducing the intensity of the “fight or flight” response.

  • Akathisia and Movement Disorders: Often used off-label to manage severe restlessness induced by antipsychotic medications or to treat Restless Legs Syndrome (RLS).

  • Acute Manic Episodes: Occasionally used in clinical settings as an adjunct to mood stabilizers to control the agitation associated with bipolar mania.

Mechanism of Action

Clonazepam acts as a positive allosteric modulator of the $\text{GABA}_A$ receptor. It enhances the binding of gamma-aminobutyric acid (GABA), the primary inhibitory neurotransmitter in the Central Nervous System (CNS).

When Clonazepam binds to its specific site on the receptor, it increases the frequency of chloride channel opening. This leads to an influx of chloride ions, hyperpolarizing the neuron and making it less likely to fire. This results in the characteristic anticonvulsant, sedative, and anxiolytic effects.

The Manufacturer’s Perspective: Formulation & Export

From a manufacturing and global trade standpoint, Clonazepam 2 mg is a high-precision CNS product:

  • Low-Dose Uniformity: Since the active ingredient is potent even at 2 mg, as a WHO-GMP manufacturer, we utilize validated dry blending or wet granulation to ensure absolute content uniformity, preventing “hot spots” in the batch.

  • Controlled Substance Logistics: Because Clonazepam has a potential for dependence, it is classified under Schedule IV (or similar international narcotic controls). Our Mumbai-based facility manages the strict documentation and licensing requirements needed for legal export.

  • Stability for Global Trade: Clonazepam is sensitive to moisture and light. We prioritize Alu-Alu blister packaging to ensure a stable 36-month shelf life, especially for export to Zone IVb climates (Africa, SE Asia, and Latin America).

  • Dossier Support: We provide comprehensive CTD/eCTD Dossiers and bioequivalence studies against the innovator (Rivotril/Klonopin) to facilitate registration in international B2B markets.

What is Clarithromycin 500mg used for?

In the pharmaceutical industry, Clarithromycin 500 mg is a semi-synthetic macrolide antibiotic derived from Erythromycin. As a pharmacist, I view Clarithromycin as a superior choice over older macrolides due to its improved acid stability, better tissue penetration, and its active metabolite (14-hydroxyclarithromycin) which provides synergistic antimicrobial activity.

Primary Clinical Uses

  • Helicobacter pylori Eradication: A critical component of “Triple Therapy” (usually combined with Amoxicillin and a Proton Pump Inhibitor like Omeprazole) to treat peptic ulcers and prevent recurrence.

  • Lower Respiratory Tract Infections: Highly effective for community-acquired pneumonia (CAP), acute exacerbations of chronic bronchitis, and “atypical” pneumonias caused by Legionella or Mycoplasma.

  • Upper Respiratory Tract Infections: Used for acute maxillary sinusitis, tonsillitis, and pharyngitis, especially in patients allergic to Penicillins.

  • Skin and Soft Tissue Infections: Treatment of uncomplicated infections like cellulitis, folliculitis, and erysipelas.

  • MAC Prophylaxis: Used to prevent or treat disseminated Mycobacterium avium complex (MAC) infections in immunocompromised patients (e.g., those with HIV/AIDS).

Mechanism of Action

Clarithromycin is primarily bacteriostatic. It works by penetrating the bacterial cell wall and binding to the 50S ribosomal subunit.

By binding at this specific site, it inhibits translocation, the process where the growing peptide chain moves along the ribosome. This halts bacterial protein synthesis, effectively preventing the bacteria from growing and multiplying, allowing the host’s immune system to clear the infection.

The Manufacturer’s Perspective: Formulation & Export

From a manufacturing and global trade standpoint, Clarithromycin 500 mg is a high-value antibiotic requiring specialized expertise:

  • Overcoming Bitterness: The Clarithromycin API is notoriously bitter. As a WHO-GMP manufacturer, we utilize advanced film-coating technology or specialized taste-masking polymers to ensure the 500 mg tablet is palatable for patients.

  • Acid Stability: Unlike Erythromycin, Clarithromycin is stable in gastric acid. However, we still optimize our formulation to ensure consistent dissolution and bioavailability, aiming for bioequivalence with the innovator (Biaxin/Klacid).

  • Stability for Global Trade: Clarithromycin is sensitive to moisture. We prioritize Alu-Alu blister packaging to guarantee a 24–36 month shelf life, particularly for export to Zone IVb climates (Africa, Southeast Asia, and the Middle East).

  • B2B & Registration: Our Mumbai-based hub provides comprehensive CTD/eCTD Dossiers and stability data to support our international partners in registering this essential antibiotic.

What is tab Citicoline used for?

In the pharmaceutical industry, Citicoline (CDP-Choline) tablets—typically manufactured in 500 mg and 1000 mg strengths—are classified as nootropic and neuroprotective agents. As a pharmacist, I view Citicoline as a “brain-building block” because it provides the essential components for repairing neuronal membranes and increasing neurotransmitter levels.

Primary Clinical Uses

  • Acute Ischemic Stroke: Administered to minimize the extent of brain damage and improve motor and cognitive recovery following a stroke.

  • Traumatic Brain Injury (TBI): Used to reduce the severity and duration of post-traumatic coma and accelerate functional recovery.

  • Cognitive Decline & Dementia: Prescribed for age-related memory loss, Alzheimer’s disease, and vascular dementia to enhance memory and attention.

  • Glaucoma & Optic Neuropathy: Increasingly used in ophthalmology to protect retinal ganglion cells and slow the progression of vision loss.

  • Parkinson’s Disease: Often used as an adjunctive therapy to Levodopa to improve motor function and reduce the required dose of dopamine-replacement therapy.

Mechanism of Action

Citicoline is a complex molecule that breaks down into choline and cytidine upon ingestion. These components then cross the Blood-Brain Barrier and work through three main pathways:

Membrane Phospholipid Synthesis: It serves as a precursor for phosphatidylcholine, the primary structural component of neuronal membranes. This helps repair damaged neurons.

Neurotransmitter Support: It increases the synthesis of acetylcholine, the primary neurotransmitter involved in memory and learning.

ATP Preservation: It enhances mitochondrial function and prevents the accumulation of free radicals, protecting brain cells from oxidative stress.

The Manufacturer’s Perspective: Formulation & Export

From a manufacturing and global trade standpoint, Citicoline is a high-value neuro-specialty product:

  • API Purity & Stability: Citicoline is highly hygroscopic (absorbs moisture). As a WHO-GMP manufacturer, we utilize Alu-Alu blister packaging and climate-controlled production areas to ensure the tablets do not degrade or become sticky during their 24-month shelf life.

    Dose Versatility: We manufacture both 500 mg and 1000 mg tablets, often with a “break-line” for easy titration. For advanced recovery, we also develop Citicoline + Piracetam combinations.

  • Niche Market Reach: This is a high-demand item for neurology clinics and specialized B2B distributors in the CIS, Southeast Asia, and the Middle East.

  • Regulatory Readiness: Our Mumbai hub provides comprehensive CTD/eCTD Dossiers and stability data for Zone IVb, facilitating smooth registration for international pharmaceutical trade.

What is Ciprofloxacin 500mg and Tinidazole 600 mg used for?

In the pharmaceutical industry, the combination of Ciprofloxacin (500 mg) and Tinidazole (600 mg) is a powerful broad-spectrum antimicrobial therapy. As a pharmacist, I view this as a “dual-action” formulation designed to cover nearly all likely pathogens in mixed infections, combining a potent fluoroquinolone with an advanced antiprotozoal/anaerobic agent.

Primary Clinical Uses

  • Gastrointestinal Infections: Highly effective for infectious diarrhea, bacillary dysentery, and amoebic dysentery where both bacteria and protozoa (like Giardia or E. histolytica) may be present.

  • Gynecological Infections: Used to treat Pelvic Inflammatory Disease (PID), bacterial vaginosis, and mixed vaginal infections.

  • Intra-abdominal Infections: Management of complex infections within the abdominal cavity, often following surgery or trauma.

  • Dental Infections: Used for severe dental abscesses or periodontitis where anaerobic bacteria are prevalent.

  • Prophylaxis: Occasionally used as a surgical prophylaxis to prevent post-operative infections in contaminated or “dirty” surgeries.

Mechanism of Action: The Synergistic Approach

This combination attacks pathogens on two distinct fronts:

Ciprofloxacin (500 mg): A fluoroquinolone that inhibits DNA Gyrase and Topoisomerase IV. It prevents bacterial DNA from unwinding and replicating, leading to rapid cell death. It primarily targets aerobic Gram-negative and some Gram-positive bacteria.

Tinidazole (600 mg): A second-generation nitroimidazole. Once it enters a cell, it is reduced to form highly reactive free radicals that bond with the DNA of anaerobic bacteria and protozoa, causing strand breakage and cell death. It has a longer half-life and better side-effect profile than Metronidazole.

The Manufacturer’s Perspective: Formulation & Export

From a manufacturing and global trade standpoint, this FDC (Fixed-Dose Combination) is a high-demand export item:

  • Bilayer Tablet Technology: Given the different physical properties and dosages (500mg/600mg), we often use bilayer compression or specialized granulation to ensure stability and consistent release profiles for both APIs.

  • Taste Masking: Both APIs are inherently bitter. As a WHO-GMP manufacturer, we utilize a robust film-coating process to ensure the tablet is palatable and easy for patients to swallow.

  • Stability for Export: Tinidazole is sensitive to light and moisture. We utilize Alu-Alu blister packaging to guarantee a 36-month shelf life, especially for export to Zone IVb regions (Africa, SE Asia, and the Middle East).

  • Global Registration: Our Mumbai facility provides comprehensive CTD/eCTD Dossiers and stability data to support our international B2B partners in rapid market entry.

What is Ciprofloxacin 100mg used for?

In the pharmaceutical industry, Ciprofloxacin 100 mg is a second-generation fluoroquinolone antibiotic. As a pharmacist, I view this specific low-strength dosage as a targeted therapeutic tool, primarily utilized in pediatric care or for very specific, uncomplicated adult infections where higher doses (250 mg or 500 mg) are not clinically necessary.

Primary Clinical Uses

  • Uncomplicated Urinary Tract Infections (UTIs): Frequently used for short-course treatment of acute, uncomplicated cystitis in women.

  • Pediatric Applications: Used to treat complicated UTIs and pyelonephritis in children (ages 1-17), where the dosage is strictly weight-based.

  • Post-Exposure Inhalation Anthrax: Part of the prophylactic regimen for children and adults following exposure to Bacillus anthracis.

  • Cystic Fibrosis: Management of pulmonary exacerbations caused by Pseudomonas aeruginosa in pediatric patients.

  • Gonorrhea: Though resistance has limited its use, it was historically used as a single 100 mg dose for uncomplicated urethral and endocervical infections.

Mechanism of Action

Ciprofloxacin is a rapidly bactericidal agent. It works by inhibiting two essential bacterial enzymes: DNA Gyrase (Topoisomerase II) and Topoisomerase IV.

By targeting these enzymes, Ciprofloxacin prevents the bacteria from “unzipping” and repairing their DNA during replication. This leads to irreversible DNA damage and rapid bacterial cell death. Its broad-spectrum activity is particularly effective against Gram-negative pathogens like E. coli and Pseudomonas.

The Manufacturer’s Perspective: Formulation & Export

From a manufacturing and global trade standpoint, Ciprofloxacin 100 mg requires precise quality controls:

  • API Purity: As a WHO-GMP manufacturer, we ensure the Ciprofloxacin Hydrochloride API meets strict BP/USP/IP standards, specifically monitoring for the “Ethylenediamine” impurity.

  • Taste Masking: Ciprofloxacin is extremely bitter. We utilize advanced film-coating technology to ensure the 100 mg tablet is palatable, especially given its frequent use in adolescent and pediatric populations.

  • Stability for Global Trade: Ciprofloxacin is light-sensitive. We utilize Alu-Alu or opaque PVC/PVDC blister packaging to maintain its 36-month shelf life during export to hot and humid Zone IVb regions (Africa and Southeast Asia).

  • B2B & Tender Supply: This strength is a staple for pediatric hospital tenders and international NGOs. Our Mumbai facility provides full CTD/eCTD Dossiers to support rapid registration for our B2B partners.

Is Cinnarizine a sleeping pill?

To give you a direct, technical answer: No, Cinnarizine is not classified as a sleeping pill. It is officially categorized as an antihistamine and a calcium channel antagonist.

However, as a pharmacist, I can tell you that the confusion is common because drowsiness is its most frequent side effect. In the pharmaceutical trade, we often refer to it as a “sedating antihistamine.”

Primary Clinical Uses

Cinnarizine is primarily manufactured and exported for:

  • Motion Sickness: Prevention and treatment of nausea and vomiting during travel.

  • Vestibular Disorders: Managing balance issues like Vertigo, Tinnitus (ringing in the ears), and Ménière’s disease.

  • Cerebral & Peripheral Circulatory Disorders: Improving blood flow in conditions like Raynaud’s disease or memory/concentration issues in the elderly.

Mechanism of Action: Why it makes you sleepy

Cinnarizine works through a dual pathway:

L-type Calcium Channel Blockade: It inhibits the influx of calcium ions into arterial smooth muscle cells, causing vasodilation and improving microcirculation in the inner ear.

H1-Receptor Antagonism: It blocks histamine receptors. Unlike “non-drowsy” antihistamines (like Cetirizine), Cinnarizine easily crosses the Blood-Brain Barrier. Once in the brain, it suppresses the vestibular system (which controls balance) but also interferes with the wakefulness-promoting effects of histamine in the central nervous system, leading to sedation.

The Manufacturer’s Perspective: Export & Formulation

If you are looking to include this in your trading portfolio or promote it on your digital platforms, here are the technical highlights:

  • Standard Strengths: Typically manufactured as 25 mg (for motion sickness) and 75 mg (for vestibular/circulatory issues).

  • Stability: Cinnarizine is highly stable but sensitive to light. We utilize PVC/PVDC or Alu-Alu blister packaging to ensure a 36-month shelf life for export to hot Zone IVb climates.

  • Market Position: It is a high-demand item in B2B marketplaces for “Travel Health” and “Geriatric Care” segments.

  • Regulatory Status: It is widely available in Europe, India, and Southeast Asia, though it is not FDA-approved in the USA, which is a key detail for your exporting strategy.

What is Cimetidine 400mg used for?

In the pharmaceutical industry, Cimetidine 400 mg is the pioneer H2-receptor antagonist (H2RA) used to suppress gastric acid secretion. While newer proton pump inhibitors (PPIs) have gained popularity, Cimetidine remains a vital, cost-effective therapeutic option for managing acid-peptic disorders, especially in international markets where affordability is a priority.

Primary Clinical Uses

  • Duodenal and Gastric Ulcers: Indicated for the short-term treatment of active ulcers and as maintenance therapy to prevent recurrence.

  • Gastroesophageal Reflux Disease (GERD): Relieves symptoms like heartburn and acid regurgitation caused by the backflow of stomach acid into the esophagus.

  • Zollinger-Ellison Syndrome: Manages pathological hypersecretory conditions where the stomach produces excessive amounts of acid.

  • Prophylaxis of GI Bleeding: Used in critical care settings to prevent stress-induced ulcers and upper gastrointestinal bleeding.

  • Off-label Dermatological Use: Occasionally used in high doses for the treatment of viral warts (verrucae) due to its immunomodulatory properties.

    Mechanism of Action

Cimetidine works by competitively inhibiting histamine at the H2-receptors located on the basolateral membrane of the gastric parietal cells.

By blocking these receptors, it inhibits both the basal (fasting) and stimulated (food-induced) secretion of gastric acid. This results in a significant reduction in the volume of gastric juice and its hydrogen ion concentration, allowing the mucosal lining to heal.

The Manufacturer’s Perspective: Formulation & Export

From a manufacturing and global trade standpoint, Cimetidine 400 mg is a high-volume, “essential medicine” staple:

  • Drug-Drug Interactions (CYP450): As a pharmacist, you know Cimetidine is a potent inhibitor of several cytochrome P450 enzymes (e.g., 1A2, 2C9, 2D6). In our professional labeling and dossiers, we emphasize these interactions to ensure patient safety when co-administered with drugs like Warfarin or Theophylline.

  • Stability for Global Markets: Cimetidine is a stable molecule, but as a WHO-GMP manufacturer, we utilize PVC/PVDC or Alu-Alu blister packaging to ensure its 36-month shelf life remains intact during export to Zone IVb climates (Africa, SE Asia, and Latin America).

  • B2B & Public Health Tenders: Because Cimetidine is often more affordable than modern PPIs, it remains a high-demand item for government health tenders and low-cost B2B distribution networks.

  • Regulatory Readiness: Our Mumbai-based facility provides comprehensive CTD/eCTD Dossiers and stability data (BP/USP/IP) to facilitate rapid registration for our international partners.

What is Cilostazol 50 mg used for?

In the pharmaceutical industry, Cilostazol 50 mg is a specific phosphodiesterase III (PDE3) inhibitor with potent antiplatelet and vasodilatory properties. As a pharmacist, I view Cilostazol as a unique therapeutic agent because, unlike standard antiplatelets like Aspirin, it actively improves blood flow by dilating the arteries while simultaneously preventing clot formation.

Primary Clinical Uses

  • Intermittent Claudication: The primary indication for Cilostazol is the reduction of symptoms of intermittent claudication (leg pain, cramping, or tiredness while walking) in patients with Peripheral Arterial Disease (PAD). It increases the distance patients can walk without pain.

  • Secondary Stroke Prevention: In some regions, it is used as an alternative or adjunct for the prevention of ischemic stroke, particularly in patients who cannot tolerate other antiplatelet therapies.

  • Percutaneous Coronary Intervention (PCI): Occasionally used off-label to prevent restenosis after stent placement.

  • Buerger’s Disease (Thromboangiitis Obliterans): Used to improve circulation in the small and medium-sized arteries of the hands and feet.

Mechanism of Action

Cilostazol works through a dual-action biochemical pathway:

Inhibition of PDE3: By inhibiting the phosphodiesterase III enzyme, Cilostazol increases the levels of cyclic adenosine monophosphate (cAMP) within platelets and blood vessel walls.

Antiplatelet Effect: Higher cAMP levels in platelets prevent them from aggregating (clumping), which reduces the risk of thrombus formation.

Vasodilation: Increased cAMP in the vascular smooth muscle cells leads to relaxation of the arteries (vasodilation), which directly increases blood flow to the limbs.

The Manufacturer’s Perspective: Formulation & Export

From a manufacturing and global trade standpoint, Cilostazol 50 mg is a specialized cardiovascular product:

  • Bioavailability Challenges: Cilostazol is practically insoluble in water. As a WHO-GMP manufacturer, we utilize micronization technology to reduce particle size, ensuring consistent dissolution and optimal absorption.

  • Dose Titration: We manufacture both 50 mg and 100 mg strengths. The 50 mg tablet is essential for patients who require a lower dose due to side effects like headaches or for those taking co-medications (like CYP3A4 inhibitors) that increase Cilostazol levels.

  • Stability for Export: We utilize Alu-Alu blister packaging to protect the tablets from moisture and light, ensuring a 24-month shelf life for export to Zone IVb regions (Africa, SE Asia, and the Middle East).

  • Regulatory Support: Our Mumbai-based facility provides comprehensive CTD/eCTD Dossiers and comparative dissolution data against the innovator (Pletal) to support international registration and B2B trade.

What is Trypsin Chymotrypsin Tablet 100000 used for?

In the pharmaceutical industry, Trypsin-Chymotrypsin tablets (standardized at 100,000 Armour Units) are a potent proteolytic enzyme combination. As a pharmacist, I view this formulation as a highly effective “biological response modifier” used to accelerate the resolution of inflammatory edema and promote tissue repair following trauma or surgery.

Primary Clinical Uses

  • Post-Operative Inflammation: Extensively used after surgical procedures (orthopedic, gynecological, or general surgery) to reduce swelling, hematoma (bruising), and pain at the incision site.

  • Traumatic Injuries: Indicated for the management of accidental injuries, such as sprains, strains, fractures, and sports-related soft tissue trauma.

  • Chronic Respiratory Conditions: Used as an adjunctive therapy in conditions like bronchitis and sinusitis to thin out thick mucus secretions (mucolytic effect), making them easier to expectorate.

  • Pelvic Inflammatory Disease (PID): Often prescribed in gynecology to resolve inflammation and improve the penetration of antibiotics into the affected tissues.

  • Tooth Extractions: Frequently used in dentistry to minimize post-extraction swelling and pain.

Mechanism of Action

Trypsin and Chymotrypsin are enzymes that act as anti-inflammatory catalysts. Unlike NSAIDs (which inhibit COX enzymes), these proteolytic enzymes work through the following pathways:

Fibrinolysis: They break down fibrin deposits that form around inflamed areas. These fibrin walls often “wall off” the infection, trapping fluid and preventing antibiotics from reaching the site.

Restoring Microcirculation: By clearing fibrin and cellular debris, these enzymes restore the flow of blood and lymph in the micro-vasculature. This reduces edema (swelling) and allows the body’s natural defense mechanisms to clear the inflammation.

TNF-$\alpha$ Modulation: They help regulate pro-inflammatory cytokines, preventing an excessive or prolonged inflammatory response.

The Manufacturer’s Perspective: Formulation & Export

From a manufacturing and global trade standpoint, Trypsin-Chymotrypsin is a technically sensitive biological product:

  • Enteric Coating (Crucial): These enzymes are proteins that would be instantly destroyed by stomach acid. As a WHO-GMP manufacturer, we utilize a high-quality enteric coating that ensures the tablet remains intact in the stomach and only dissolves in the $pH$-neutral environment of the small intestine.

  • Potency & Standardization: We measure efficacy in Armour Units (or AU). Ensuring that each tablet provides exactly 100,000 units requires precise API handling and environmental controls to prevent enzymatic degradation during the manufacturing process.

  • Stability for Export: Enzymes are heat-sensitive. We prioritize Alu-Alu blister packaging to protect the tablets from moisture and temperature fluctuations during transit to Zone IVb regions.

  • B2B & Surgical Supply: This is a high-demand item for surgical hospitals and orthopedic clinics. Our Mumbai facility provides the CTD/eCTD Dossiers and stability data required for international registration and hospital tenders.

Add to cart